Answers are grounded in this paper and cite their sources.
Background: Single-cancer screening (SCS) reduces mortality for select cancers but overlooks many malignancies that contribute to overall cancer deaths. Screening whole-body MRI (sWB-MRI) is an emerging modality for multi-cancer detection (MCD) with potential in preventive care. We assessed the diagnostic yield and clinical implications of sWB-MRI in a preventive health population. Methods: In this retrospective single-center study, we evaluated 1,011 individuals without known active cancer who underwent noncontrast, multiparametric sWB-MRI (1.5 T with diffusion-weighted imaging) from January to December 2022. Of 2,632 individuals scanned, 1,044 (39.7%) completed routine clinical follow-up telephone calls approximately 12-16 months later; 33 with known active cancer were excluded. Imaging spanned head-to-ankle anatomy for the vast majority of studies, with structured reports available for primary care physician review. The primary outcome was the observed cancer detection percentage (CDP), based on patient-reported histopathological diagnoses of malignancy following evaluation or management of findings initially identified on sWB-MRI, along with the distribution of cancer types relative to established screening categories. Results: The cohort consisted of 52% males, with a mean age of 56.4 ± 12.9 years. Tissue sampling was reported in 4.9% (n = 50), with diagnostic-intent tissue sampling (dTS) in 4.1% (n = 41). The overall cancer detection percentage (O-CDP) was 2.18% (95% CI: 1.37%-3.28%), with 3.0% observed among those aged 65-79 years. Of 22 detected cancers, 15 (68.2%) belonged to cancer types outside the five predefined SCS categories, and one (4.5%) was of unknown primary origin. Fourteen cancers (63.6%) were retrospectively estimated to have localized disease. Two additional interval breast cancer diagnoses (0.2%) were reported during follow-up but were not identified in the original sWB-MRI reports. Clinically significant noncancer findings (e.g., aneurysms, meningiomas, hepatosteatosis) were associated with reported subsequent clinical interventions or monitoring. Conclusions: In this population, sWB-MRI enabled broad detection of some cancers not typically identified by SCS. The findings highlight the need to explore MCD imaging in larger, risk-stratified cohorts to inform screening policy, address missed cancer burdens, and enhance early detection strategies in population health. Prospective studies with standardized reporting frameworks (ONCO-RADS) and long-term outcomes are needed to support broader clinical integration.
No takes yet. Share an insight, caveat, or question.
Datta et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: